A comparative study of concomitant boost radiation versus concomitant boost with concurrent chemoradiation versus standard fractionation chemoradiation in locally advanced head-and-neck cancer.

A comparative study of concomitant boost radiation versus concomitant boost with concurrent chemoradiation versus standard fractionation chemoradiation in locally advanced head-and-neck cancer. J Cancer Res Ther. 2020 Apr-Jun; 16(3):478-484.

View in: PubMed

subject areas

Adult
Aged
Antineoplastic Agents
Carcinoma, Squamous Cell
Chemoradiotherapy
Cisplatin
Combined Modality Therapy
Disease-Free Survival
Female
Head and Neck Neoplasms
Humans
Male
Middle Aged
Neoplasm Staging
Patient Safety
Prospective Studies
Survival Rate
Treatment Outcome

authors with profiles

Vivek Kaushal